Physician profile
Stephen Reich
NPI 1023125507
$1,044.47
in general payments reported to CMS, 2019-2025
10 companies · $68.43 in 2025
The $68.43 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19.68 · 2022: $60.52 · 2023: $234 · 2024: $661 · 2025: $68.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $964.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $964.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $343.82 | 2023-2024 | |
| Mdd US Operations, LLC | $278.49 | 2024 | Gocovri |
| Amneal Pharmaceuticals LLC | $240.98 | 2022-2025 | Crexont, Rytary |
| Biosense Webster, INC. | $54.98 | 2023 | Carto 3 |
| Lilly USA, LLC | $45.73 | 2024-2025 | Kisunla, Amyvid |
| Kyowa Kirin, INC. | $23.04 | 2024 | Nourianz |
| Allergan, INC. | $19.68 | 2021 | |
| Insightec,INC | $19.52 | 2024 | Exablate |
| Biohaven Pharmaceutical Holding Company LTD. | $18.23 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Reich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.